J2406 – Injection, oritavancin (kimyrsa), 10 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2406
- Long description
- Injection, oritavancin (kimyrsa), 10 mg
- Short description
- Injection, oritavancin 10 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2021
- Last change
- October 1, 2021 – No change
Frequently asked questions
What is HCPCS code J2406?
J2406 is a HCPCS Level II code for injection, oritavancin (kimyrsa), 10 mg.
Does Medicare cover J2406?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2373 – Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
- J2374 – Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
- J2400 – Injection, chloroprocaine hydrochloride, per 30 ml
- J2401 – Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 – Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403 – Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404 – Injection, nicardipine, 0.1 mg
- J2405 – Injection, ondansetron hydrochloride, per 1 mg
- J2407 – Injection, oritavancin (orbactiv), 10 mg
- J2410 – Injection, oxymorphone hcl, up to 1 mg
- J2425 – Injection, palifermin, 50 micrograms
- J2426 – Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427 – Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428 – Injection, paliperidone palmitate extended release (erzofri), 1 mg
- J2430 – Injection, pamidronate disodium, per 30 mg
- J2440 – Injection, papaverine hcl, up to 60 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.